Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

CDC Media Relations
Media Home | Contact Us
US Department of Health and Human Services logo and link

Media Relations Links
About Us
Media Contact
Frequently Asked Questions
Media Site Map

CDC News
Press Release Library
Transcripts
MMWR Summaries
B-Roll Footage
Upcoming Events

Related Links
Centers at CDC
Data and Statistics
Health Topics A-Z
Image Library
Publications, Software and Other Products
Global Health Odyssey
Find your state or local health department
HHS News
National Health Observances
Visit the FirstGov Web Site
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394


MMWR
Synopsis for October 19, 2001

The MMWR is not embargoed this week.

  1. Update: Investigation of Anthrax Associated With Intentional Exposure and Interim Public Health Guidelines October 2001
  2. Recognition of Illness Associated With the Intentional Release of a Biological Agent
  3. Weekly Update: West Nile Virus Activity United States, October 1016, 2001

Synopsis for October 19, 2001

Update: Investigation of Anthrax Associated With Intentional Exposure and Interim Public Health Guidelines October 2001

Four confirmed U.S. cases of anthrax have resulted from intentional use of Bacillus anthracis spores.

 
PRESS CONTACT:
Division of Media Relations

CDC, Office of Communication
(404) 6393286
 

These are the first confirmed cases of anthrax associated with intentional exposure. For rapid identification of threat agents, such as B. anthracis, states should have access to the Laboratory Response Network for Bioterrorism which links state and local public health laboratories with advanced capacity laboratories. Recommended regimens for postexposure prophylaxis are available. This report includes information on the three clinical forms of anthrax (inhalation, gastrointestinal and cutaneous); recommended postexposure treatment regimens; handling letters/packages and environmental management of exposed areas; handling laboratory specimens possibly infected with anthrax (for healthcare providers); and handling anthrax and other biological agent threats (for the general public).

 

Recognition of Illness Associated With the Intentional Release of a Biological Agent

Following the terrorists incidents in New York City and Washington, D.C., CDC recommended heightened surveillance for any unusual disease occurrences.

 
PRESS CONTACT:
Division of Media Relations

CDC, Office of Communication
(404) 6393286
 

This report provides basic guidance that can be implemented to improve recognition of potential biological agents. After the terrorist attacks of September 11, 2001, state and local health departments initiated various activities to improve surveillance and response, ranging from enhancing communications to conducting special surveillance projects. Healthcare providers, clinical laboratory personnel, infection control professionals, and health departments play critical and complementary roles in recognizing and responding to illness caused by the release of biologic agents. This report includes basic information for healthcare providers for recognizing anthrax, plague, botulism, smallpox, inhalational tularemia, and hemorrhagic fever.

 

Weekly Update: West Nile Virus Activity United States, October 1016, 2001

PRESS CONTACT:
Division of Media Relations

CDC, Office of Communication
(404) 6393286
 
The report summarizes surveillance data for West Nile Virus (WNV) activities in the United States. The report includes information on human cases and deaths, infected birds and other animals, and WNV-positive mosquito pools.




 

Media Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed Friday, October 19, 2001
URL:

Centers for Disease Control and Prevention
Office of Communication